Business
How Moderna went from coronavirus sequence to a phase-1-ready vaccine candidate in 42 Days – Motley Fool Australia
The biotech got a little help from Amazon’s AWS.
Moderna(NASDAQ:MRNA), one of the leaders in the race to develop a coronavirus vaccine, was able to take the initial coronavirus sequence and get a vaccine candidate, mRNA-1273, ready for a phase 1 clinical trial in just 42 days.
The biotech’s use of Amazon Web Services (AWS), the cloud-based computing service run by Amazon (NASDAQ:AMZN), enabled this quick development. Moderna runs its Drug Design Studio on AWS, which allows it to design its mRNA drug candidates quickly.
The potential drugs ar…
-
Noosa News23 hours agoToyah Cordingley’s accused killer Rajwinder Singh had sand ‘scattered’ throughout car, Cairns court hears
-
Noosa News8 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
Noosa News24 hours agoAcademics hit back after leading universities oppose key environmental legislation
-
Business23 hours ago3 top ASX ETFs to buy for your SMSF in December